UPADACITINIB (RINVOQ®)

Clinical Indication

Rheumatoid arthritis

Comments

In line with NICE TA665

Date of classification

February 2020

Review date

March 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).